On Monday shares of Acceleron Pharma, Inc. (NASDAQ:XLRN) closed at $32.68. Celgene (NASDAQ:CELG) and Acceleron Pharma Inc. (NASDAQ:XLRN) announced that the United States Food and Drug Administration (FDA) has granted Fast Track designations to luspatercept for two separate indications; the use of luspatercept for the treatment of patients with transfusion dependent beta-thalassemia and the use of luspatercept for the treatment of patients with non-transfusion dependent beta-thalassemia. Celgene and Acceleron are jointly developing luspatercept.
Mondelez International, Inc. (NASDAQ:MDLZ) in last trading activity fell -1.11% to close at $40.00. Company weekly performance is 1.70% while its quarterly performance stands at 8.13%. Mondelez International, Inc. (NASDAQ:MDLZ) is -1.26% away from its 52 week high. Mondelez International Inc. (NASDAQ:MDLZ)plans to cut several hundred jobs at a Chicago bakery that makes Chips Ahoy and Oreo cookies and other snack foods. The Deerfield based company said the total number of layoffs will depend on a decision about where to locate four new manufacturing lines.
On last trading day UIL Holdings Corporation (NYSE:UIL) increased 0.94% to close at $50.27. Its volatility for the week is 1.87% while volatility for the month is 1.94%. UIL’s sales growth for past 5 years was 12.70% and its EPS growth for past 5 years was 0.00%. UIL Holdings Corporation (NYSE:UIL) monthly performance is 0.98%. UIL Holdings Corporation (NYSE:UIL) announced that its Board of Directors declared a quarterly dividend of $0.432 per share on its Common Stock at today’s Board meeting. This dividend is payable July 1, 2015 to shareowners of record at the close of business on June 15, 2015.
Perficient Inc. (NASDAQ:PRFT) has 3.10% insider ownership while its institutional ownership stands at 71.50%. In last trading activity company’s stock closed at $19.83. Zacks upgraded shares of Perficient Inc (NASDAQ:PRFT) from a hold rating to a buy rating in a research note released on Monday morning. They currently have $22.00 target price on the stock.
On last trading day ZS Pharma, Inc. (NASDAQ:ZSPH) increased 6.40% to close at $52.19. Its volatility for the week is 6.14% while volatility for the month is 5.87%. ZS Pharma, Inc. (NASDAQ:ZSPH) monthly performance is 28.77%. On May 11, ZS Pharma, Inc. (NASDAQ:ZSPH) reported its financial results for the first quarter ended March 31, 2015. ZS Pharma reported net loss attributable to common shareholders of $21.9 million, or $1.05 per diluted share, for the quarter ended March 31, 2015, compared with a net loss attributable to common shareholders of $10.7 million, or $6.60 per diluted share, for the same period in 2014.